You are here

  • Home
  • Archive
  • Volume 66, Issue Suppl 2
  • PTU-082 Real world impact of rifaximin-Αlpha use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: a post-hoc analysis of the impress study

Article metrics

Article menu
Download PDFPDF
Liver
PTU-082 Real world impact of rifaximin-Αlpha use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: a post-hoc analysis of the impress study

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20171901
Jul 2017400
Aug 20171202
Sep 20171001
Oct 2017800
Nov 2017600
Dec 20171000
Jan 20185402
Feb 20181601
Mar 20182401
Apr 20181803
May 20181800
Jun 20181200
Jul 2018800
Aug 2018401
Sep 2018400
Nov 20181000
Dec 2018400
May 2019200
Jul 2019403
Sep 2019200
Oct 2019200
Nov 2019600
Dec 2019600
Jan 2020200
Feb 2020300
Mar 2020100
May 2020200
Jul 2020400
Sep 20205000
Oct 2020200
Nov 2020902
Feb 20211000
Mar 20211402
Nov 2021800
Dec 2021800
Jan 20221400
Feb 2022600
Mar 2022400
Apr 20221001
May 20221200
Jun 2022500
Jul 2022400
Aug 20221101
Sep 2022400
Oct 2022401
Nov 20221200
Dec 2022400
Jan 2023400
Feb 2023600
Mar 2023800
Apr 2023200
May 20231201
Jun 2023500
Jul 2023800
Nov 2023800
Dec 2023200
Jan 20241001
Feb 2024200
Mar 2024600
Total539024